Mumbai: No Relief For Wholesalers Who Sold Fake Covid-19 Medicine

Mumbai : A sessions court in Dindoshi on Friday rejected anticipatory bail pleas of two drug wholesalers booked by the Vanrai and Samta Nagar police stations for stocking spurious Favimax 400 drug, widely used in the treatment of Covid-19 infection.

On 24 May, upon a tip-off, the Food and Drug Administration (FDA) raided three wholesalers in the suburbs of Kandivali and Goregaon areas. In Kandivali, it found fake drug worth Rs 21 lakh and in Goregaon Rs 1 crore. Accordingly, Samta Nagar police station had booked wholesaler Nilesh Khimani and Vanrai police booked Manjiri Kadam by Vanrai police for the offences of cheating, forgery and under provisions of the Drugs and Cosmetics Act.

Both had approached the court apprehending arrest and claimed in their pleas that they did not have the knowledge that the drugs were not genuine, that they were only sellers and had no role in the offence.

Additional Public Prosecutor Sachin Jadhav had opposed grant of relief to them and told the court that the duo procured the fake drug, having knowledge that they are not genuine, from the main accused Sudeep Mukherjee, the owner of Max Relief Healthcare in Himachal Pradesh. Probe by the FDA had found that the company did not exist, but its ‘owner’ Mukherjee sold the fake drugs manufactured by a pharma lab employee in Uttar Pradesh, whom another person helped package it. Prosecutor Jadhav further pointed out that it was only a profiteering motive during a pandemic, with which the duo purchased a huge stock of the fake drug. Their custodial interrogation was required, he told the court, to find where they had sold the spurious drug. Additional Sessions Judge SU Baghele rejected relief to the duo.

  • Related Posts

    • Pharma
    • May 15, 2024
    • 82 views
    Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

    Solan: The working of the Drug Control Administration (DCA), Baddi, has come under the scanner as despite large-scale sale of psychotropic drugs in the last one year, the management of Biogenetic…

    • Pharma
    • May 15, 2024
    • 122 views
    DCA Forms Task Force To Investigate Smilax And Biogenetic Operations

    Shimla: In a startling revelation, pharmaceutical giants Smilax and Biogenetic find themselves embroiled in a controversy surrounding the alleged illicit sale of banned drugs across state borders. The companies, previously regarded…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

    Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

    DCA Forms Task Force To Investigate Smilax And Biogenetic Operations

    DCA Forms Task Force To Investigate Smilax And Biogenetic Operations

    CDSCO Constitutes Eight-Member Subcommittee To Look Into OTC Classification

    CDSCO Constitutes Eight-Member Subcommittee To Look Into OTC Classification

    Piramal Pharma open to partnerships in OTC; eyes further debt reduction

    Piramal Pharma open to partnerships in OTC; eyes further debt reduction

    Indian Chest Society Unveils Special Booklet On Cough Management

    Indian Chest Society Unveils Special Booklet On Cough Management

    Patient Exposes Blood Syndicate At Bhind Govt Hospital

    Patient Exposes Blood Syndicate At Bhind Govt Hospital